An LPL–specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1-Reference-Cited by-同舟云学术

An LPL–specific monoclonal antibody, 88B8, that abolishes the binding of LPL to GPIHBP1

Published:2016-10 Issue:10 Volume:57 Page:1889-1898
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Allan Christopher M.,Larsson Mikael,Hu Xuchen,He Cuiwen,Jung Rachel S.,Mapar Alaleh,Voss Constance,Miyashita Kazuya,Machida Tetsuo,Murakami Masami,Nakajima Katsuyuki,Bensadoun André,Ploug Michael,Fong Loren G.,Young Stephen G.,Beigneux Anne P.

Funder

National Heart, Lung, and Blood Institute

Fondation Leducq

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference37 articles.

1. Clearing factor, a heparin-activated lipoprotein lipase. II. Substrate specificity and activation of coconut oil;Korn;J. Biol. Chem.,1955

2. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart;Korn;J. Biol. Chem.,1955

3. Idiopathic hyperlipemia: metabolic studies in an affected family;Havel;J. Clin. Invest.,1960

4. Lipoprotein lipase: genetics, lipid uptake, and regulation;Merkel;J. Lipid Res.,2002

5. Biochemistry and pathophysiology of intravascular and intracellular lipolysis;Young;Genes Dev.,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of lipoprotein lipase in mouse plasma with a sandwich enzyme-linked immunosorbent assay;Journal of Lipid Research;2024-04

2. The GPIHBP1-LPL complex and its role in plasma triglyceride metabolism: Insights into chylomicronemia;Biomedicine & Pharmacotherapy;2023-12

3. The lipoprotein lipase that is shuttled into capillaries by GPIHBP1 enters the glycocalyx where it mediates lipoprotein processing;Proceedings of the National Academy of Sciences;2023-10-23

4. A protein of capillary endothelial cells, GPIHBP1, is crucial for plasma triglyceride metabolism;Proceedings of the National Academy of Sciences;2022-08-29

5. ANGPTL4 silencing via antisense oligonucleotides reduces plasma triglycerides and glucose in mice without causing lymphadenopathy;Journal of Lipid Research;2022-07